Articles

Poll

Podcasts

Slideshows

Videos

Dermatology

The HCPLive dermatology page is a resource for medical news and expert insights on skin disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for dermatologic conditions, and more.

Findings highlight the ongoing burden of generalized pustular psoriasis and suggest patients may benefit from targeted biologic therapies like the FDA-approved spesolimab.

Most Patients With GPP Failed to Achieve Clear Skin on Small-Molecule Therapy

In ARRECTOR, patients reported symptom relief and improved quality of life as early as week 2, with strong tolerability and safety through week 8.

Roflumilast Foam 0.3% Effective for Scalp, Body Psoriasis in Phase 3 Trial

Based on reduced FOXP3+ expression in patients, investigators have drawn a strong correlation between MetS due to psoriasis and immune dysregulation.

Immune Dysregulation and Metabolic Syndrome Closely Related, Study Suggests

Study Highlights Topical Omega-3 Polyunsaturated Fatty Acid Benefits in Skin Disease

Findings suggest pediatric patients with guttate or inverse psoriasis may warrant evaluation for pharyngeal or anogenital bacterial infections.

Bacterial Infections Involved in Certain Pediatric Psoriasis Subtypes, Study Suggests

Overall, older treatment strategies such as methotrexate and phototherapy still led the way for cost-effectiveness.

Ixekizumab Efficacious and Cost Effective for Biologic Treatment of PsO

This FDA news recap highlights some of the most notable approvals and actions by the organization in dermatology during Q2 2025.

5 FDA Approvals in Dermatology: Q2 Recap

In our recap for Q2 in dermatology, we spotlight clinical trial findings, recent updates, and advancements in different disease states.

Q2 2025 Recap: Dermatology News and Updates

In the BE BRIGHT trial presented at SDPA 2025, patients receiving continuous bimekizumab therapy maintained high PASI 90 and PASI 100 response rates over 5 years.

Bimekizumab Shows Sustained 5-Year Efficacy, Safety in Plaque Psoriasis Patients 

At SDPA 2025, Gordon presented on the future of dermatology, discussing current drugs being evaluated for atopic dermatitis, psoriasis, and hidradenitis suppurativa.

Promising Drugs in the Pipeline for Atopic Dermatitis, Psoriasis, HS

The HCPLive plaque psoriasis page is a resource for medical news and expert insights on psoriasis. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for psoriatic disease, and more.